Medicines For Europe Recommends Changes To EU Pharmaceutical Legislation

Prioritizes Digitalization Of Regulatory Framework And Incentivizing Manufacturing Investments

Recommendations
The off-patent industry body has given feedback on the European Commission’s Pharmaceutical Strategy legislation • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Policy & Regulation

More from Generics Bulletin